Key Points Both XLK and FTEC charge the same low expense ratio, but FTEC holds more stocks and has much lower assets under management. FTEC has a slightly deeper historical drawdown and marginally higher volatility. Both funds share significant overlap in their top holdings, but FTEC offers broader diversification across nearly 300 stocks. These 10 stocks could mint the next wave of millionaires ›...
Key Points Both XLK and FTEC charge the same low expense ratio, but FTEC holds more stocks and has much lower assets under management. FTEC has a slightly deeper historical drawdown and marginally higher volatility. Both funds share significant overlap in their top holdings, but FTEC offers broader diversification across nearly 300 stocks. These 10 stocks could mint the next wave of millionaires › The State Street Technology Select Sector SPDR ETF (NYSEMKT:XLK) and the Fidelity MSCI Information Technology Index ETF (NYSEMKT:FTEC) both target the U.S. technology sector, but they take slightly different approaches. XLK tracks a narrower slice of the S&P 500, while FTEC tracks a broader MSCI index covering more companies. This comparison examines cost, performance, risk, portfolio composition, and other features to help investors determine which approach may appeal more. Snapshot (cost & size) Metric XLK FTEC Issuer SPDR Fidelity Expense ratio 0.08% 0.08% 1-yr return (as of Jan. 27, 2026) 23.76% 20.57% Dividend yield 0.54% 0.43% AUM $92 billion $17 billion Beta (5Y monthly) 1.21 1.28 Both ETFs are equally affordable with a 0.08% expense ratio, but XLK offers a slightly higher dividend yield. The most notable difference in cost-related factors is scale: XLK’s assets under management (AUM) is more than five times larger than FTEC’s. Performance & risk comparison Metric XLK FTEC Max drawdown (5 y) -33.56% -34.95% Growth of $1,000 over 5 years $2,129 $2,210 What's inside FTEC tracks the MSCI USA IMI Information Technology 25/50 Index, holding 289 stocks from various corners of the technology sector. Its top three positions — Nvidia, Microsoft, and Apple — make up more than 44% of assets, but the remaining holdings provide broader exposure across the sector. XLK also targets technology, but with only 70 holdings. Its largest holdings match FTEC’s, but those three stocks make up just under 40% of the fund. Both ETFs carry no notable structural quirks and track major technolo...
Apple is fairly valued according to our Discounted Cash Flow (DCF) , but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act. When all of those projected cash flows are discounted back to today, the model arrives at an intrinsic value of US$237.57 per share. Compared with the recent share price of US$259.48, this implies Apple trades a...
Apple is fairly valued according to our Discounted Cash Flow (DCF) , but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act. When all of those projected cash flows are discounted back to today, the model arrives at an intrinsic value of US$237.57 per share. Compared with the recent share price of US$259.48, this implies Apple trades at roughly a 9.2% premium to the DCF estimate, so the stock screens as slightly overvalued on this model. Apple’s latest twelve month free cash flow is about US$124.1b. Using a 2 stage Free Cash Flow to Equity model, analysts provide explicit forecasts out to 2030, with projected free cash flow of US$193.0b in that year. Beyond the first few years, Simply Wall St extends the trajectory using its own assumptions to create a full 10 year stream of cash flows in US$. A Discounted Cash Flow, or DCF, model takes the cash Apple is expected to generate in the future and discounts those amounts back to what they are worth today. It is essentially asking what a rational buyer might pay today for all those future cash flows in one lump sum. Apple scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown . On Simply Wall St’s 6 point valuation framework, Apple currently scores 1 out of 6 , which suggests only one of the checks screens as undervalued. Next we will walk through how different valuation approaches line up on Apple today and then finish with a way to think about value that goes beyond any single model. These moves have played out against a steady stream of product news, ecosystem updates and broader tech sector headlines that can quickly shift how investors think about potential growth and risk. For long term holders and new investors alike, separating short term news flow from what is actually baked into the price is key to judging whether the current level still makes sense. Apple shares last closed at US$259.48, with retur...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. BeOne Medicines (ONC) has been drawing investor attention after a recent stretch of mixed short term returns, with a 1 day decline and flat performance over the past week alongside gains over the past month. See our latest analysis for BeOne Medicines. At a sh...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. BeOne Medicines (ONC) has been drawing investor attention after a recent stretch of mixed short term returns, with a 1 day decline and flat performance over the past week alongside gains over the past month. See our latest analysis for BeOne Medicines. At a share price of $340.38, BeOne Medicines has paired a 9.44% year to date share price return with a 51.29% total shareholder return over the past year. This points to momentum that has been stronger for long term holders than for recent traders cautiously reassessing risk and growth potential. If BeOne Medicines has put oncology back on your radar, it could be a good moment to scan the wider sector using Simply Wall St's healthcare stocks. With BeOne Medicines trading at $340.38 alongside an indicated discount to both analyst targets and an intrinsic value estimate, the key question for investors is whether there is still a buying opportunity or if the market is already pricing in future growth. Most Popular Narrative: 15.2% Undervalued At $340.38 versus a narrative fair value of about $401.52, BeOne Medicines is framed as materially undervalued, with that gap anchored in ambitious growth assumptions. BeOne's strong revenue growth (41% YoY in Q2; updated full-year guidance of $5 to $5.3B) is underpinned by rapid demand expansion for differentiated, best-in-class oncology therapies like BRUKINSA, supported by a growing, aging population and increased global healthcare spending, both of which point to a sustainably expanding addressable market and future revenue growth. Read the complete narrative. Curious what kind of revenue path and margin profile support that fair value gap, and how long earnings growth is expected to stay elevated? The narrative leans on aggressive expansion, rising profitability, and a richer earnings multiple than many large biotechs. If you want to see ex...
Key Points Both Ford and General Motors return significant value to shareholders, albeit in different ways. Ford's dividend yields nearly 4.5%, and the company often dishes out supplemental dividends. General Motors has announced $16 billion in share buybacks since 2023 -- a different approach. 10 stocks we like better than General Motors › When it comes to designing, producing, and selling highly...
Key Points Both Ford and General Motors return significant value to shareholders, albeit in different ways. Ford's dividend yields nearly 4.5%, and the company often dishes out supplemental dividends. General Motors has announced $16 billion in share buybacks since 2023 -- a different approach. 10 stocks we like better than General Motors › When it comes to designing, producing, and selling highly profitable full-size trucks and SUVs, there may not be two closer rivals than Detroit's own Ford Motor Company (NYSE: F) and General Motors (NYSE: GM). Though fierce rivals in vehicle segments, the two automakers share a core value of returning significant value to shareholders. Let's dive into how and why the automakers approach returning value differently, and why it's a big win for long-term investors. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Paying you direct One popular reason investors have for scooping up shares of Ford is the automaker's high-yield dividend. In fact, Ford offers investors a combination of value, as the company trades at a modest price-to-earnings ratio of 11, as well as a dividend yield of 4.4% -- much higher than the S&P 500's average yield of just over 1.1%. The difference a dividend can make in a long-term investment is significant. Take Ford, for instance. Over the past decade you can see the modest share price returns compared to the much larger total value returns that include dividends. One unique aspect of Ford's dividend is that the interests of the Ford family are aligned with shareholders'. That's because the automaker has a special class of shares held by the Ford family that come with not only the common dividend but also substantial voting rights. It's well known that the Ford family enjoys the significant payout, and would prefer the company's dividend payments remain consistent and strong. Ford is aiming to return 40% to 50% of its annual f...
Apple is fairly valued according to our Discounted Cash Flow (DCF) , but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act. When all of those projected cash flows are discounted back to today, the model arrives at an intrinsic value of US$237.57 per share. Compared with the recent share price of US$259.48, this implies Apple trades a...
Apple is fairly valued according to our Discounted Cash Flow (DCF) , but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act. When all of those projected cash flows are discounted back to today, the model arrives at an intrinsic value of US$237.57 per share. Compared with the recent share price of US$259.48, this implies Apple trades at roughly a 9.2% premium to the DCF estimate, so the stock screens as slightly overvalued on this model. Apple’s latest twelve month free cash flow is about US$124.1b. Using a 2 stage Free Cash Flow to Equity model, analysts provide explicit forecasts out to 2030, with projected free cash flow of US$193.0b in that year. Beyond the first few years, Simply Wall St extends the trajectory using its own assumptions to create a full 10 year stream of cash flows in US$. A Discounted Cash Flow, or DCF, model takes the cash Apple is expected to generate in the future and discounts those amounts back to what they are worth today. It is essentially asking what a rational buyer might pay today for all those future cash flows in one lump sum. Apple scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown . On Simply Wall St’s 6 point valuation framework, Apple currently scores 1 out of 6 , which suggests only one of the checks screens as undervalued. Next we will walk through how different valuation approaches line up on Apple today and then finish with a way to think about value that goes beyond any single model. These moves have played out against a steady stream of product news, ecosystem updates and broader tech sector headlines that can quickly shift how investors think about potential growth and risk. For long term holders and new investors alike, separating short term news flow from what is actually baked into the price is key to judging whether the current level still makes sense. Apple shares last closed at US$259.48, with retur...
Indonesia’s stock-market rout spilled into sovereign bonds last week as foreign investors dumped debt alongside equities. Global funds sold a net $202 million of Indonesian government bonds on Wednesday and Thursday, the biggest two-day outflow since October, according to Finance Ministry data released over the weekend. The selling more than halved year-to-date inflows to about $147 million, the d...
Indonesia’s stock-market rout spilled into sovereign bonds last week as foreign investors dumped debt alongside equities. Global funds sold a net $202 million of Indonesian government bonds on Wednesday and Thursday, the biggest two-day outflow since October, according to Finance Ministry data released over the weekend. The selling more than halved year-to-date inflows to about $147 million, the data show. The bond selloff came as Indonesian equities briefly suffered their steepest drop since the Asian Financial Crisis, after MSCI Inc. warned the market may be downgraded to frontier status unless transparency improves. The turmoil spread across assets, with the rupiah snapping its longest rally since October and government bond yields edging higher. Sentiment toward Indonesian bonds had already waned on concerns over the government’s spending path and central bank independence, compounded by President Prabowo Subianto appointing a relative as deputy governor of Bank Indonesia. MSCI Warning Triggers Worst Indonesian Stock Rout Since 1998 Indonesia Market Chiefs Step Down as Pressure From MSCI Mounts Why Indonesia Risks Losing Its Emerging Market Status: QuickTake